Engflag

Tylex CD

Quick links to important sections

Tylex CD

Tylex CD_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tylex CD

Quick Facts

Property Description
Active Ingredients Acetaminophen (Paracetamol) and Codeine Phosphate
Form Oral solid dosage form (Tablet or capsule)
Pharmacological Class Narcotic analgesic combination
Common Use Management of moderate to severe acute pain
Rx Status Prescription Only Medicine (POM)

What Type of Medicine is Tylex CD? (Identity and Classification)

Tylex CD is classified as a prescription medicine and a fixed-dose combination product, belonging to the narcotic analgesic combination pharmacological class. This formulation is clinically recognized for providing enhanced pain relief compared to its components used alone. It is distinguished from single-ingredient opioid products and over-the-counter (OTC) pain relievers by its dual-component formulation and its status as a controlled substance in many jurisdictions, reflecting its potential for central nervous system (CNS) effects.

The Active Components: Acetaminophen and Codeine (Composition and Form)

The core of Tylex CD is the pairing of Acetaminophen (Paracetamol), a synthetic non-opioid compound, with Codeine Phosphate, which is derived from a natural opiate alkaloid. This combination is primarily manufactured as an oral solid dosage form—specifically a capsule or tablet—intended for systemic relief. Unlike generic acetaminophen/codeine combinations, Tylex CD contains the specific salt form codeine phosphate hemihydrate, reinforcing its defined pharmaceutical identity.

General Purpose of the Dual-Action Analgesic (High-Level Benefit)

The general purpose of this medication is the management of moderate to severe pain that is insufficiently relieved by non-opioid options. It is typically utilized for short-term relief in acute pain scenarios, such as post-operative dental procedures or minor injuries. The combination design leverages the synergistic effect of the two active ingredients, which provides a more robust and complete analgesic outcome than could be achieved if either component were used at a comparable therapeutic dose alone.

What side effects are possible with Tylex CD?

Possible side effects and safety information

The safety profile of the acetaminophen and codeine phosphate combination is formally classified in regulatory documents by the frequency of adverse reactions and the body systems affected. The most frequently reported adverse reactions, classified as Common or Very Common, affect the Nervous System and Gastrointestinal System, including drowsiness, dizziness, nausea, vomiting, and constipation.

Documented Serious Adverse Reactions

Official labeling mandates the prominent documentation of serious adverse reactions associated with each active component. These include the potential for Life-Threatening Respiratory Depression, primarily linked to the codeine component, and the risk of Acute Liver Failure or Hepatotoxicity related to the acetaminophen component. The use of opioid analgesics also exposes individuals to the documented risks of addiction, abuse, and misuse, which may lead to overdose and death.

Population-Specific Safety Considerations

The regulatory profile specifies safety constraints for certain patient groups. The combination is contraindicated in children younger than 12 years of age and in breastfeeding mothers, as codeine and its active metabolite are excreted into breast milk. Furthermore, its use is restricted in patients who are CYP2D6 ultra-rapid metabolizers, a genetic variation that increases the risk of opioid toxicity. Older adults may exhibit increased sensitivity to the CNS effects, requiring careful safety consideration.

Exposure-Related Safety Patterns

Risk assessment notes that the potential for severe adverse reactions, such as respiratory depression, is heightened during the initiation of therapy or following a dosage increase. Long-term exposure to the opioid component carries a documented risk for the development of physical dependence and tolerance. The combination is also restricted in situations involving severe respiratory depression or severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The Tylex CD overdose profile is defined by the dual toxicity risks associated with its active components, demanding immediate emergency action as mandated by regulatory authorities.

Documented Manifestations

Overdose presents with distinct, severe clinical signs. Early manifestations of acetaminophen toxicity often include nausea, vomiting, pallor, sweating, and abdominal pain, progressing to signs of hepatic damage such as jaundice and confusion in the delayed phase. Opioid toxicity from codeine manifests as Central Nervous System (CNS) depression, extreme sleepiness, miosis (pinpoint pupils), stupor, and life-threatening respiratory depression.

Severe outcomes documented in official labeling include acute liver failure, circulatory collapse, and fatal respiratory depression.

Mandated Emergency Actions

  • Seek immediate medical attention or call emergency services immediately upon any suspicion of overdose, regardless of whether symptoms are currently present.
  • Urgent medical care is required upon the observation of unusual sleepiness, breathing difficulties, or confusion.

Official Management Notes

Management is symptomatic and supportive. The specific antidote for acetaminophen toxicity is N-acetyl cysteine (NAC). Naloxone is used to manage severe opioid toxicity. Regulatory guidance emphasizes required hospital monitoring and observation of vital signs.

Special consideration is noted for children under 12 and ultra-rapid metabolizers, who face a significantly higher risk of fatal respiratory depression.

Therapeutic Uses of Tylex CD

Tylex CD is indicated for the temporary management of moderate to moderately severe pain. It may be used to help alleviate discomfort when other options may not be suitable or have not provided adequate relief. Clinical scenarios where this medication may be employed include pain following surgical procedures, pain related to injuries or trauma, and certain types of persistent discomfort.

The benefit a patient receives is the mitigation of painful symptoms, which supports an improved comfort level and may support the user’s ability to maintain routine functional mobility. Primary indications for Tylex CD include assistance in treating pain associated with musculoskeletal issues, acute dental procedures, and symptoms of specific chronic conditions.

Quick Fact: Relief for Moderate to Moderately Severe Pain Tylex CD's function is to help reduce the severity of pain symptoms, acting as part of a structured pain management plan.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Tylex CD? — Official Regulatory Information

The eligibility for Tylex CD, a combination product containing acetaminophen and codeine, is strictly defined by regulatory documents based on patient population and pre-existing conditions.

Eligibility Scope

Category Official Regulatory Status
Populations for whom use is allowed Adults and adolescents ge 12 years of age.
Populations for whom use is not recommended Adolescents (12-18 years) with compromised respiratory function.
Populations for whom use is contraindicated Children younger than 12 years of age; patients who are breastfeeding; and individuals who are CYP2D6 ultra-rapid metabolisers of codeine.

Eligibility-Related Restrictions

Age-Related Rules: The medicine is contraindicated in all children under 12 years old. It is also contraindicated for any patient under 18 years of age following tonsillectomy and/or adenoidectomy. Older adults require caution due to increased sensitivity, and a dose adjustment may be necessary.

Condition-Specific Rules: Tylex CD is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting, and known gastrointestinal obstruction. Use with caution is advised for patients with severe hepatic or renal impairment, or those with endocrine disorders such as hypothyroidism.

Connection to the overall eligibility profile: Official regulatory documents define eligibility primarily through absolute contraindications related to age, specific procedures, and genetic metabolic risks associated with the codeine component. Additional restrictions limit use in populations with pre-existing conditions affecting organ function, ensuring adherence to the regulatory scope of use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Tylex CD (Acetaminophen and Codeine Phosphate) documents several clinically significant drug-drug and drug-substance interactions. Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated, and a mandatory 14-day separation period is required after discontinuing an MAOI. This restriction applies to substances such as Isocarboxazid and Linezolid.

A primary documented risk involves Pharmacodynamic Interactions with Central Nervous System (CNS) depressants, including other opioids, sedatives, hypnotics, and muscle relaxants. Concurrent use with these medicines or with Alcohol may result in severe additive effects, officially described as profound sedation and respiratory depression. The combination with Serotonergic Drugs (e.g., SSRIs, SNRIs) may also lead to the onset of Serotonin Syndrome, and Anticholinergic Drugs may increase the risk of paralytic ileus.

Pharmacokinetic Interactions primarily occur through the Cytochrome P450 enzymes. Inhibitors or inducers of CYP2D6 and CYP3A4 formally alter the plasma concentrations of codeine and its active metabolite, morphine, potentially resulting in reduced efficacy or increased risk of adverse events. Additionally, the acetaminophen component may increase the anticoagulant effect of coumarin derivatives like Warfarin, increasing the risk of bleeding. Population-specific cautions are noted for the elderly and patients with hepatic or renal impairment, due to potentially slower clearance.

Mechanism of Action

The compound's primary action involves selective inhibition of the Cyclooxygenase-2 ( COX-2) enzyme. It operates by accessing the catalytic site and forming a specific, time-dependent bond with key amino acid residues. This interaction competitively blocks the conversion of arachidonic acid into prostaglandin precursors, thereby reducing the synthesis of Prostaglandin E2 ( PGE2) and other inflammatory mediators at the cellular level. This selectivity ensures the preservation of COX-1 enzyme activity, which maintains basal PGE2 synthesis. A secondary mechanism involves activity modulation within the central nervous system. The compound acts as a partial antagonist at the N-methyl-D-aspartate ( NMDA) receptor complex in the spinal dorsal horn. This action attenuates the excessive calcium influx triggered by excitatory neurotransmitters, which in turn reduces the hyperexcitability of neurons involved in nociceptive signaling. The overall mechanism results in dual peripheral and central modulation of signaling pathways.

Dosage and Administration Information

Administration Guidelines

This section outlines the principles for using Tylex CD, detailing the prescribed manner of administration and dosing constraints.

Administration Scope

Instruction Detail
Route of administration Oral administration only, typically as a capsule or tablet.
Standard Adult Dose One or two dose units, which contain 500 mg of acetaminophen and 30 mg of codeine phosphate per unit.
Dosing Frequency The dose may be repeated as necessary at intervals of not less than 6 hours.
Maximum Dose Constraints The maximum intake of acetaminophen from all sources must not exceed 4000 mg per 24-hour period. The codeine component should not exceed 240 mg per day.

Procedural and Duration Instructions

Instruction Detail
Intake Method The capsule or tablet is instructed to be swallowed whole with water.
Dose Coordination It is specified not to take this product concurrently with any other medicines containing paracetamol/acetaminophen.
Treatment Duration Treatment should be restricted to the lowest effective dose for the shortest period of time, with a maximum duration generally limited to 3 days.
Usage in Adolescents Dosing guidelines are established for adolescents, with a lower maximum daily intake for the 12-to-15-year age group than for adults and older adolescents.

This collection of instructions defines a short-term usage protocol for the medication. The usage protocol focuses on minimizing the total exposure time (three days) and preventing dose stacking by mandating a minimum six-hour interval between administrations and imposing absolute limits on the total daily intake of both active components.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Acute Conditions

Research has explored how the drug, a combination of acetaminophen and the opioid codeine, was investigated regarding pain relief. Early single-dose, placebo-controlled trials examined the use of the combination for moderate to severe postoperative pain in adults.

  • A meta-analysis of these studies reported that the combination provided a clinically useful level of pain relief in approximately 40% to 50% of patients, depending on the dosage, compared with less than 20% of participants receiving a placebo.
  • The addition of codeine to acetaminophen was associated with a longer duration of relief and a reduced need for rescue medication compared to acetaminophen alone.

Mechanism and Safety Profile Studies

Studies have investigated the drug's profile across various adult populations. Standard safety monitoring in all trials included assessment of adverse events and lab parameter changes (e.g., liver enzymes).

  • Codeine is metabolized by the liver enzyme CYP2D6 into morphine, its active component for pain relief. Studies have identified genetic variations in this enzyme that may influence the drug's effectiveness and safety, particularly regarding the risk of respiratory depression.
  • Acetaminophen has been extensively studied, with research reporting a risk of hepatotoxicity (liver damage) when the total daily dosage exceeds 4,000 mg, often involving the concomitant use of multiple acetaminophen-containing products.
  • Due to the opioid component, research has explored risks including the potential for drug dependence, abuse, and misuse. Regulatory warnings emphasize the need for caution, especially when co-administered with other central nervous system depressants, such as benzodiazepines or alcohol.

How should Tylex CD be stored and disposed of?

Storage and Disposal of Tylex CD

Tylex CD must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F), with temperatures not exceeding 30 C. The product must be kept in the original container, kept tightly closed, and protected from moisture to maintain its labeled stability. All medication must be stored out of the sight and reach of children.

Due to the presence of codeine, a controlled substance, specific disposal rules apply. The preferred method for discarding unused or expired Tylex CD is through an authorized drug take-back program. If a take-back program is not readily available, the FDA's guidance permits flushing the product down the toilet to prevent accidental ingestion or misuse.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tylex CD found in:

A-Z Index: